International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?

被引：28
|
作者：
Pang, Jing [1 ]
Lansberg, Peter J. [2 ,3 ]
Watts, Gerald F. [1 ,4 ]
机构：
[1] Univ Western Australia, Sch Med & Pharmacol, GPO Box X2213, Perth, WA 6847, Australia
[2] Ctr Translat Mol Med Translat Res Infrastruct CTM, Eindhoven, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[4] Royal Perth Hosp, Dept Cardiol, Lipid Disorders Clin, Cardiometab Serv, Perth, WA 6001, Australia
来源：
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 2016年 / 23卷 / 05期
关键词：
Familial hypercholesterolemia; Models of care; Heart disease; Risk; Prevention; Screening; Treatment; Cost-effectiveness; Education; Registries; CORONARY-ARTERY-DISEASE; ASSOCIATION EXPERT PANEL; RISK-FACTORS; HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; STATIN TREATMENT; YOUNG-PATIENTS; LIPID-LEVELS; FOLLOW-UP;
D O I：
10.5551/jat.34108
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Several international guidelines and consensus statements have recently been published on the care of familial hypercholesterolemia (FH)(1-3)). They agree on approaches to case detection and cascade testing, protocols in children, lifestyle and drug treatment strategies, and indications for lipoprotein apheresis. However, most countries in the world still do not have integrated, systematic FH screening programs to adequately detect and treat cases in the community. This study provides a comprehensive overview of recent and future international initiatives for closing the gaps in the care of FH.
引用
收藏
页码：505 / 519
页数：15
相关论文
共 50 条
12345